Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

man von Willebrand Factor (vWF)

• Human Plasma-Derived Fibrinogen

• Recombinant Human Fibrinogen

• Human Plasma-Derived Factor XI

• Human Plasma-Derived Factor X

• Recombinant Human Factor X

• Human Plasma-Derived Factor XIII

• Recombinant Human Factor XIII

• Alternative Procoagulants & Adjuncts

• Human Plasma-Derived Prothrombin Complex Concentrates

• Gene Therapy of Hemophilia

• Topical Human Plasma-Derived Fibrinogen and Thrombin Products

• Topical Plasma-Derived Thrombin Products

• Topical Recombinant Human Factor II (Prothrombin)

• Alternative Topical Hemostats

 

7 ) Human Growth Hormone (hGH)

 

• 2012 Sales of Branded Somatropin Products in Regulated Markets

• 2012 Sales of Selected Somatropin Products in Non-Regulated Markets

• 1st Generation: Somatropin in Regulated Markets

 

• 1st Generation: Biosimilar Somatropin in Regulated Markets

• 2nd Generation: Injectable Somatropin in Slow-release Formulation in Regulated Markets

• 2nd Generation: Injectable Long-acting Somatropin in Regulated Markets

• 2nd Generation: Injection-Free Somatropin in Regulated Markets

 

• 1st Generation: Somatropin Products in Non-Regulated Markets

• 2nd Generation: Injectable Long-Acting Somatropin Products in Non-Regulated Markets

• Non-Medical, Legal Uses of Somatropin

 

8 ) FSH, hCG and LH - Assisted Reproductive Technology (ART)

• Urinary FSH-Containing Products: Menotropins

• Recombinant Menotropins

• 1st Generation Purified Human Urinary FSH

• 2nd Generation Recombinant Human FSH

• Biosimilar Recombinant Human FSH

• 2n
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... 2014 Pressure BioSciences, Inc. (OTCQB: PBIO) ... the development and sale of high pressure-based sample ... today announced that Professor Ruedi Aebersold ... reproducible, and robust method to allow – for ... on small needle biopsy samples by mass spectrometry ...
(Date:10/27/2014)... Investor-Edge has initiated coverage on the following ... Insmed Inc. (NASDAQ: INSM ), BioCryst Pharmaceuticals ... DYAX ), and Oncothyreon Inc. (NASDAQ: ONTY). ... at: http://investor-edge.com/register . On Friday, October ... 0.69%, the Dow Jones Industrial Average advanced 0.76%, to ...
(Date:10/26/2014)... 2014 The report "Protective Coatings Market ... Global Trends & Forecast to 2019", defines and segments ... of volume consumed and value generated. The protective coatings ... 2014 to 6,701.3 KT by 2019, at a CAGR ... market data tables and 22 figures spread through 219 ...
(Date:10/25/2014)... Angeles, California (PRWEB) October 23, 2014 ... ), a specialty pharmaceutical company devoted to bringing ... out-licensing partnerships in 2015. , ViaDerma has developed ... which allows for rapid mass transfer of pharmaceutical ... the body to provide immediate localized therapy. The ...
Breaking Biology Technology:Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 2Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 3Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 4Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 5Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 2Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 3Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
... America, Inc.  (OTC Bulletin Board: CBAI ) announced ... www.bancovida.com ) to offer umbilical cord blood collection services in ... will allow BancoVida and Cord Blood America to educate prospective ... of storing their baby,s umbilical cord blood.  The stem cells ...
... 26, 2011 Infrared Systems International (OTCBB: IFRS) announces ... strategies for continued success. Most recently, the ... its subsidiary, Infrared Applications, Inc. (IAI).  The distribution marks ... from one engaged in the aerospace industry to one ...
... Shire plc (LSE: SHP, NASDAQ: SHPGY ... U.S. Food and Drug Administration (FDA) has granted marketing approval ... attacks of hereditary angioedema (HAE) in adults 18 years of ... challenges gaining rapid access to acute treatment such as the ...
Cached Biology Technology:Cord Blood America Enters Agreement With BancoVida, a Cord Blood Collection Company in San Juan, Puerto Rico 2Infrared Systems International Reflects on Past and Looks Forward to the Future 2Infrared Systems International Reflects on Past and Looks Forward to the Future 3FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 6
(Date:10/29/2014)... October 27, 2014 — Cambridge, MA and Hebei, China ... the complete, high quality sequencing of the Jujube genome. ... Rhamnaceae family, and the Jujube genome is particularly difficult ... other complicating factors. It is the first time that ... sequenced. This study has been recently published in ...
(Date:10/29/2014)... – Ghrelin is a hormone released by the stomach ... commonly viewed as a psychoactive substance that primarily affects ... food. , This knowledge, combined with findings from ... has the potential to stimulate alcohol craving. , Dr. ... and found that, as they had anticipated, alcohol craving ...
(Date:10/29/2014)... a large cohort of kidney cancer patients in Europe ... -- and reveals an apparent link between exposure to ... Romania. , The research, by an international team led ... Innovation Centre in Montreal, underscores the importance of investigating ... found in plants of the Aristolochia genus, also has ...
Breaking Biology News(10 mins):BGI Tech and Hebei Agricultural University complete the genome sequencing of the jujube tree 2Ghrelin stimulates an appetite for drinking alcohol 2Study sheds light on genetic architecture of kidney cancer 2Study sheds light on genetic architecture of kidney cancer 3
... and computers to the drug-discovery process, researchers at ... predict protein separation behavior directly from protein structure. ... the time it takes to bring pharmaceuticals to ... array of biotechnology applications, including bioprocessing, drug discovery, ...
... Melbourne based company Metabolic Pharmaceuticals Limited recently announced ... The company will begin clinical trials in humans ... the toxin in normal males, and later its ... diabetes. , From the University of Melbourne's Department ...
... cells are controversial. Many people know that stem cells can grow ... red blood cell to a muscle cell to a brain cell. ... and renew themselves long after the point where other cells stop ... Washington offer one of the first clues as to why stem ...
Cached Biology News:Rensselaer researchers develop approach that predicts protein separation behavior 2Rensselaer researchers develop approach that predicts protein separation behavior 3Molecular miners find pain relief drugs from the sea 2Molecular miners find pain relief drugs from the sea 3Discovery suggests why stem cells run through stop signs 2
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
Mouse Wnt-9b Affinity Purified Polyclonal Ab Keywords: Wnt 9b Protein Family: Cancer Stem Cell Markers, Wnt Ligands...
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
... Purpose -- The Varian 1200 ... highest level of flexibility and ... affordable, easy-to-use system. The complete ... guarantees success with today's applications ...
Biology Products: